Loading...
XSHG603368
Market cap995mUSD
Dec 25, Last price  
18.39CNY
1D
-0.49%
1Q
9.40%
Jan 2017
-41.87%
IPO
12.80%
Name

Guangxi LiuYao Group Co Ltd

Chart & Performance

D1W1MN
XSHG:603368 chart
P/E
8.55
P/S
0.35
EPS
2.15
Div Yield, %
4.87%
Shrs. gr., 5y
-0.05%
Rev. gr., 5y
12.18%
Revenues
20.81b
+9.23%
2,728,120,4163,558,017,6594,547,800,3645,655,346,7156,507,659,4917,559,395,4089,446,982,83211,714,529,70714,856,825,31915,668,662,97017,134,823,19119,052,830,88020,811,902,878
Net income
850m
+21.11%
83,529,009104,354,454149,417,374169,797,276208,378,346321,011,524401,379,997528,185,273685,426,064711,713,755563,817,377701,518,265849,591,844
CFO
594m
+17.37%
133,379,61660,506,31822,329,80100108,385,117022,300,201412,912,525664,685,872332,878,819506,430,637594,407,507
Dividend
Jun 11, 20240.6 CNY/sh
Earnings
May 16, 2025

Profile

Guangxi LiuYao Group Co., Ltd. engages in the distribution and retail of pharmaceutical products in China. The company was founded in 1981 and is based in Liuzhou, China. Guangxi LiuYao Group Co., Ltd is a subsidiary of Liuzhou Liangmianzhen Co., Ltd.
URL
http://www.lzyy.cn/
IPO date
Dec 04, 2014
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
20,811,903
9.23%
19,052,831
11.19%
17,134,823
9.36%
Cost of revenue
19,175,014
17,480,121
15,752,794
Unusual Expense (Income)
NOPBT
1,636,888
1,572,709
1,382,030
NOPBT Margin
7.87%
8.25%
8.07%
Operating Taxes
136,777
131,426
113,595
Tax Rate
8.36%
8.36%
8.22%
NOPAT
1,500,111
1,441,284
1,268,435
Net income
849,592
21.11%
701,518
24.42%
563,817
-20.78%
Dividends
(353,760)
(173,909)
(217,460)
Dividend yield
5.17%
2.58%
3.16%
Proceeds from repurchase of equity
(21,995)
BB yield
0.32%
Debt
Debt current
3,281,362
3,149,486
2,788,845
Long-term debt
1,288,886
1,246,390
1,324,789
Deferred revenue
65,736
67,991
70,430
Other long-term liabilities
301,330
233,596
232,219
Net debt
1,084,764
539,868
606,320
Cash flow
Cash from operating activities
594,408
506,431
332,879
CAPEX
Cash from investing activities
(202,009)
Cash from financing activities
(397,083)
FCF
(36,358)
990,059
566,139
Balance
Cash
3,469,870
3,854,653
3,415,544
Long term investments
15,615
1,355
91,770
Excess cash
2,444,890
2,903,366
2,650,572
Stockholders' equity
5,133,629
4,415,968
3,837,386
Invested Capital
9,341,138
7,917,272
7,299,825
ROIC
17.38%
18.94%
18.40%
ROCE
13.84%
14.53%
13.88%
EV
Common stock shares outstanding
361,528
361,607
361,722
Price
18.94
1.45%
18.67
-1.94%
19.04
-11.61%
Market cap
6,847,349
1.42%
6,751,209
-1.97%
6,887,181
-11.63%
EV
8,378,237
7,687,461
7,839,685
EBITDA
1,870,611
1,775,937
1,552,427
EV/EBITDA
4.48
4.33
5.05
Interest
39,372
267,640
209,955
Interest/NOPBT
2.41%
17.02%
15.19%